Company: RNAC
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001453687-25-000075
Chunk: 34

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 34
---
 director is expected to spend the time and effort necessary to properly discharge his or her responsibilities. Accordingly, a director is expected to regularly prepare for and attend meetings of the Board and all committees on which the director sits (including separate meetings of the independent directors), with the understanding that, on occasion, a director may be unable to attend a meeting. A director who is unable to attend a meeting of the Board or a committee of the Board is expected to notify the Chairman of the Board or the Chairman of the appropriate committee in advance of such meeting, and, whenever possible, participate in such meeting via teleconference in the case of an in-person meeting. Currently, we do not maintain a formal policy regarding director attendance at the Annual Meeting; however, it is expected that absent compelling circumstances each director will attend. All of our then-incumbent directors attended all three of our stockholder meetings held in 2024, including the 2024 Annual Meeting of Stockholders.

#### Committees of the Board
Our Board has established four standing committees—Audit, Compensation, Nominating and Corporate Governance, and Science and Technology.

The current members of each of the Board committees and committee Chairs are set forth in the following chart.

| Name                             |     | Audit |     | Compensation |     | Nominating and Corporate Governance |     | Science and Technology |
| Timothy C. Barabe, M.B.A.        |     | Chair |     | -            |     | X                                   |     | -                      |
| Carsten Brunn, Ph.D.             |     | -     |     | -            |     | -                                   |     | -                      |
| Carrie S. Cox                    |     | X     |     | Chair        |     | -                                   |     | -                      |
| Nishan de Silva, M.D., M.B.A.(1) |     | X     |     | X            |     | -                                   |     | -                      |
| Murat Kalayoglu, M.D., Ph.D.(2)  |     | -     |     | -            |     | X                                   |     | Chair                  |
| Kemal Malik, M.B.B.S.            |     | -     |     | X            |     | -                                   |     | X                      |
| Michael Singer, M.D., Ph.D.      |     | -     |     | -            |     | X                                   |     | X                      |
| Timothy A. Springer, Ph.D.       |